Novel Innovation in Flow Diversion: Surface Modifications.
Flow diversion
Intracranial aneurysm
Stent
Sub-arachnoid hemorrhage
Journal
Neurosurgery clinics of North America
ISSN: 1558-1349
Titre abrégé: Neurosurg Clin N Am
Pays: United States
ID NLM: 9008004
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
entrez:
29
3
2022
pubmed:
30
3
2022
medline:
31
3
2022
Statut:
ppublish
Résumé
Flow diversion is a mainstay of modern endovascular aneurysm treatment. Several surface-modified flow diverters have been introduced with a goal to reduce rates of in-stent thrombosis and the need for dual antiplatelet therapy. Preliminary follow-up data suggest that these now commercially available devices are noninferior with respect to rates of angiographic occlusion. These data also suggest that these devices have lower rates of stent-related ischemia. In this chapter, we explore these devices in detail and discuss clinical data regarding their efficacy. We also discuss an alternative bioactive surface modification strategy that has shown in vitro and in vivo efficacy.
Identifiants
pubmed: 35346453
pii: S1042-3680(21)00107-8
doi: 10.1016/j.nec.2021.11.004
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
215-218Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure B.A. Gross is a consultant for Medtronic and MicroVention.